Author: Daemonbounty

Disclaimer : Please note that we are not associated with the ICO nor are paid for preparing this review. This is our personal opinion and contributors are advised to do their due diligence before contributing to the ICO.

Project Shivom is a very ambitious project that can change the healthcare landscape across the globe. Healthcare sector has maximum impact on our society, yet it is one of the sector that is least affected by technological advancements in other fields. Telemedicine, machine learning, artificial intelligence, data privacy etc. are still new for healthcare sector. Project Shivom aims to combine all these aspects with human genomics to help solve some of the major challenges in today's healthcare sector. Does it have the potential to do so? Do they have the qualified team for that? Do they have a community that will support their roadmap? We have analyzed all those aspects and tried to rate the ICO. Being an ICO in healthcare sector, it definitely have a social impact but during the analysis we tried to be more objective and weighed both on social and financial aspects of the ICO.

We have analysed the ICO based on the below parameters: 

1. Necessity or problem statement (12%)

2. White paper (9%)

3. Product Status (10%)

4. Team (10%)

5. ICO Pricing (7%)

6. Business Model/Revenue Source (15%)

7. Token Value Increment Options (15%)

8. Social Media Presence/Hype (10%)

9. Competitors (12%)

Below is the score we have given for each parameter and overall rating of the ICO.

Please continue reading for detailed analysis. 

1. Necessity or Problem Statement (12%)

Even though genomic sequencing is becoming popular with each passing day, there are many issues that needs to be addressed for the system to be effective for all the stake holders. There are issues related to data security and privacy. Individual's genomic data is used by third parties without explicit consent of the person. Also many a times we hear the news about data theft that pose a great risk to the society. The revenue generated from the genomic data is not at all shared with the individuals and as most of the current genomic data are stored in silos i.e. in the centralized databases of the corporations that collect DNA samples for sequencing, it becomes a bottleneck for research and development and become single point of failure. Researchers around the world don't get access to these genomic data in a timely manner which delays and complicates the clinical trial and research. Project Shivom aims to solve these by creating a genomic data hub and healthcare service platform based on blockchain. There is an acute necessity of these kind of innovation in healthcare sector and we really appreciate the novelty of the concept. We give them 9 out of 10 i this regard.

2. White paper (9%)

You can go through their whitepaper in the ‘Details’ tab.

Averagely written whitepaper. The whitepaper has all the required details including the project vision, market overview, problem statement, solution, business model and technical architecture. However, when you go through it, you will feel like there is a lack of coherence in the manner in was written. Seems like each section was written by a different person without any synergy with others. As some sentences it sounded like it was going all over the places. However, it gives a much needed details about the market condition of human genomics and the corresponding problems it faces today. The technical architecture section is well defined and we liked it. Overall we give 6 out of 10.

3. Product Status (10%)

They have a link to POC page on their website. We expected to see some details about the product. However, it has just a mock up displayed (with lorem ipsum written on it) as shown below.

We are not trying to take anything from the project but these things go a long way in adding credibility to the project. We would have really loved to check a basic POC or alpha of the product before ICO but that's how it is for most of the ICOs at the moment. We give then 5 out of 10 for this.

4. Team (10%)

They have managed to build up one of the most amazing team that we have seen till date. The CEO Axel, COO Gourish, Sally, Henry and others form an impeccable team. Their CTO Akash is one of the most notable names in India and founded the renowned Auxesis group, Indian's first blockchain company. He is also heading blockchain foundation of India and have great relationship with Indian Govt. and business fraternity. These aspects will add a lot of value for Shivom in future as it tries to build partnership with Indian Govt. Just fyi, they have already signed a MoU with Govt. of Andhra Pradesh and Akash has a big hand behind that. Overall a highly capable team who has all the talent and resources to pull off an ambitious project like this. We give them 9 out of 10 for this.

5. ICO Pricing (7%)

They are planning to sell 33% of total available 3,000,000,000 tokens to raise $33,000,000. This makes the project valued at $100,000,000. Sounds expensive? Well not really. If you understand the reach and impact of the project, they in fact may need much more than that to execute the roadmap items. They have 20% of tokens available in reserve and another 20% in growth pool which will come handy in future. However, we really didn't appreciate the fact that 24% of tokens goes to founders and advisers. That's a huge portion of tokens and it is not a good point for a project that has a huge social value associated with it. We give them 8 out of 10 for pricing.

6. Business Model/Revenue Source (15%)

The major business model for Shivom will be from data storage and sharing of human genome. As they are going to build one of the largest decentralized genome bank, it will be in huge demand in future and make a case for continuous future revenue. Apart from that they will have a peripheral healthcare marketplace around all those genomic data and this will give then second stream of revenue source. In addition, pharma companies will be able to use these data in two forms. One, to use for clinical research and would not mind paying for the same. Second, they will be able to use these user information for selective advertisement of drugs and solution to patients. Even insurance companies can utilize these data for advertising purpose. So advertising will be one of the major source of revenue in future. Overall, multiple revenue source and the best part is most of them are major revenue sources unlike other projects where the secondary revenue streams are minimal in nature. We give them 9 out of 10 in this aspect.

7. Token Value Increment Options (15%)

There are multiple use cases for OMX tokens that will help maintain and increase its valuation over time.

As mentioned in the above list, there are ample use cases for OMX token in the ecosystem. With increased popularity of the platform, the value of OMX token is bound to increase.However, till the point, OMX token is not universally accepted, the platform must support fiat currency and that may impact the value of OMX token. We give them 8 out of 10 in this aspect. 

8. Social Media Presence/Hype (10%)

Their evangelizing efforts in various social media platforms like Telegram, Facebook, Twitter, LinkedIn, are all intensive and is gathering the intended mindshare among ICO enthusiasts. 

Twitter – 40000+ followers

Facebook – 4000+ followers

Telegram – 45000+ followers

They are spending a lot of effort on marketing and that has given them huge attention. We give them 9 out of 10 in this aspect. 

9. Competitors (12%)

There are many regional players in the space which are currently active in different regions. It will be very difficult for Shivom to compete and make a mark in the initial days. Also other players, based on blockchain, like Etheal, Patientry, Medicalchain and Well will determine the level of competition that Shivom will face. However, if they provide a decent service with ubiquitous platform then they will be able to  easily penetrate the market and achieve their desired target.

Based on their roadmap and capable team, we hope that they will be able to fend of their competitor and capture market share. We give them 7 out of 10 in this aspect.

Based on our analysis we give a overall score of 87.7 out of 100 to Shivom which is an outstanding rating.

The Shivom has an interesting and novel ideathat aims to transform the Genomics field in specific and healthcare sector in general. healthcare is one of the most revenue generating sectors in the owrld and yet it is the most neglected with respect to penetration of technological innovations. Shivom aims to bridge that gap and if succeeds, it will have a huge potential to be the market leader in this segment. We also like the business model and gowth prospect of the project and having a capable team helps. We see both short term and long term demand for the OMX tokens and thus expect project supporters to benefit from it. 

We give it “Outstanding” rating and a long term investment option with low risk.